-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Sickle Cell Disease

ASH-a-Palooza
Program: Trainee Activities and Services
Session: Blood Drop: Sickle Cell Disease
Friday, December 8, 2023, 2:40 PM-2:50 PM
Friday, December 8, 2023, 3:00 PM-3:10 PM

Deepika S. Darbari, MBBS, MS

Division of Hematology, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC

Disclosures: Darbari: Novartis Pharmaceuticals Corporation: Honoraria, Membership on an entity's Board of Directors or advisory committees; Agios: Honoraria, Membership on an entity's Board of Directors or advisory committees; Novo Nordisk: Honoraria, Membership on an entity's Board of Directors or advisory committees; Global Blood Therapeutics (Pfizer): Honoraria, Membership on an entity's Board of Directors or advisory committees.